Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
424.6 INR | +0.32% | +2.45% | +4.74% |
04-30 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
04-15 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
Business Summary
Number of employees: 3,650
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
99.7
%
| 37,272 | 99.0 % | 44,963 | 99.7 % | +20.64% |
Other
0.3
%
| 377 | 1.0 % | 156 | 0.3 % | -58.73% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
93.6
%
| 27,821 | 85.9 % | 42,224 | 93.6 % | +51.77% |
India
6.4
%
| 4,563 | 14.1 % | 2,895 | 6.4 % | -36.55% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 22-01-04 | |
Chief Executive Officer | 69 | 91-03-17 | |
Mukesh Surana
DFI | Director of Finance/CFO | 44 | 22-12-29 |
Chief Tech/Sci/R&D Officer | - | - | |
P.V. Srinivas
CTO | Chief Tech/Sci/R&D Officer | - | - |
GSR Prasad
COO | Chief Operating Officer | - | 16-12-31 |
Compliance Officer | - | - | |
Sanjay Kumar
PRN | Corporate Officer/Principal | - | 21-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 13-02-18 | |
Director/Board Member | 62 | 21-12-12 | |
Director/Board Member | 67 | 02-19 | |
Chief Executive Officer | 69 | 91-03-17 | |
Director/Board Member | 66 | 23-05-15 | |
Director/Board Member | 40 | 04-12-31 | |
Director/Board Member | 64 | 12-05-30 | |
Director/Board Member | - | 01-22 | |
Director/Board Member | - | 21-12-21 | |
Chief Executive Officer | 60 | 22-01-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 242,368,716 | 129,120,408 ( 53.27 %) | 0 | 53.27 % |
Company contact information
Granules India Ltd.
My Home Hub 2nd Floor, 3rd Block
500081, Hyderabad
+91 40 6904 3500
http://www.granulesindia.comGroup companies
Name | Category and Sector |
---|---|
Granules Pharmaceuticals, Inc.
Granules Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Granules Pharmaceuticals, Inc. develops and manufactures pharmaceutical formulations. The firm manufactures tablets, pharmaceutical formulation intermediates and active pharmaceutical ingredients. The company is headquartered in Chantilly, VA. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- GRANULES Stock
- GRANULES Stock
- Company Granules India Limited